Renzo DiCarlo is Chief Executive Officer (CEO) and Member of the Board of Directors at BioPharma Services. Since 2011, Renzo has been integral in expanding BioPharma’s clinical footprint into the USA and fortifying their Bioanalytical Lab operations to meet the growing volume demand. Prior to his joining BioPharma, Renzo held senior executive management posts in the Life Sciences sector with extensive international experience working in North America, Europe, Asia and Africa. He has inspired teams to innovate and deliver first-in-world NDA approved therapeutic drugs and medical devices in a variety of cultures and languages.
- Latest FDA Guidance On Bioequivalence Studies During COVID-19
- Digital Advertising Recommendations for Clinical Research Organizations (CRO)
- Introducing All New BioPharma Services Website
- How to Book a COVID-19 Vaccine Appointment
- Renzo DiCarlo Of BioPharma Services Inc. Presents COVID-19 Vaccine Strategies To Canadian Parliament